Strides Strengthens Africa Business with Acquisition of Branded Generics from Sandoz
Strides Pharma Science Limited announced that its step-down subsidiary, Strides Pharma International AG (SPIAG), has entered into definitive agreements with […]
STRIDES-PHARMA-SCIENCE-LIMITED
Strides Expands Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib – Targeting $116M Market Opportunity
In a strategic move to further strengthen its footprint in the anti-inflammatory therapeutic segment, Strides Pharma Science Limited announced that […]
